Using the Kaplan–Meier Online Tool (http://kmplot.com/analysis/, accessed on 4 September 2022) [17], we found that BC patients with high expressions of SOX2 exhibited a decreased overall survival than patients with low expressions of SOX2 (Figure 1C). The gene discussed is SOX2; the disease is breast cancer.